2118P Perioperative sintilimab plus oxaliplatin and S-1 (SOX) versus SOX alone in resectable locally advanced gastric cancer/gastroesophageal junction cancer (GC/GEJC): A multicenter randomized phase II study (PERSIST)Xinfa Ding, Han Liang, Xin Wang et al.|Annals of Oncology|2025Cited by 1